Correlation Between Catalyst Pharmaceuticals and SunOpta

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and SunOpta at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and SunOpta into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and SunOpta, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and SunOpta and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of SunOpta. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and SunOpta.

Diversification Opportunities for Catalyst Pharmaceuticals and SunOpta

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Catalyst and SunOpta is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and SunOpta in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SunOpta and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with SunOpta. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SunOpta has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and SunOpta go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and SunOpta

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 31.01 times less return on investment than SunOpta. But when comparing it to its historical volatility, Catalyst Pharmaceuticals is 1.42 times less risky than SunOpta. It trades about 0.02 of its potential returns per unit of risk. SunOpta is currently generating about 0.38 of returns per unit of risk over similar time horizon. If you would invest  598.00  in SunOpta on August 29, 2024 and sell it today you would earn a total of  181.00  from holding SunOpta or generate 30.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  SunOpta

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
SunOpta 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SunOpta are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward-looking signals, SunOpta disclosed solid returns over the last few months and may actually be approaching a breakup point.

Catalyst Pharmaceuticals and SunOpta Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and SunOpta

The main advantage of trading using opposite Catalyst Pharmaceuticals and SunOpta positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, SunOpta can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SunOpta will offset losses from the drop in SunOpta's long position.
The idea behind Catalyst Pharmaceuticals and SunOpta pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets